Uncertainty Regarding the Safety of SGLT-2 Inhibitors Prior to PCI: the Impact of Unmeasured Confounding and Statistical Power

Cardiovascular Drugs and Therapy 2026

View at publisher

Authors: Jun Tang

DOI: 10.1007/s10557-026-07846-x

Cited by: 0

References: 3

Fields of Study & Subjects

Diabetes Treatment and Management Coronary Interventions and Diagnostics Antiplatelet Therapy and Cardiovascular Diseases

References 3